Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-24 @ 11:32 PM
NCT ID:
NCT06455956
Eligibility Criteria:
Inclusion Criteria for aim 1:
* Children with short stature and suspicion of GHD
* Subjects with organic GH deficiency
Exclusion criteria for aim 1:
-Subjects with underlying genetic conditions and chronic diseases
Inclusion Criteria for aim 2-3-5:
* patients having confirmed GHD enrolled for aim 1
* patients with growth failure and born SGA (\>4 yr of age)
* patients with Noonan and Turner syndrome and growth failure
* patients with short stature homeobox-containing gene deficiency (SHOXD) and growth failure
Inclusion Criteria for aim 4:
\- Isolated idiopathic prepubertal naive GHD subjects on long-acting versus daily GH therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
15 Years
Study:
NCT06455956
Study Brief:
Protocol Section:
NCT06455956